All files will open in a new window. To download files to your hard drive, right-click and choose "save as".
Overview of all clinical study results
Cleveland Clinic Trial by Dr. Dennis Sprecher
Published in Sprecher DL, Pearce GL (2002) Fiber-multivitamin combination therapy: a beneficial influence on lowdensity lipoprotein and homocysteine Metabolism 51, 1166-70.
Diabetes in Control Study #1 by Steven Freed and David Joffe
Published in Freed S, Joffe D (2000) The Clinical Impact of Fiber Supplementation for the Reduction of Postprandial Blood Glucose and Risk Reduction of Complications from Diabetes Diabetes in Control 12-8.
Diabetes in Control Study #2 by Steven Freed and David Joffe
Published in Freed S, Joffe D (2004) The Clinical Impact of Fiber Supplementation for the Reduction of Postprandial Blood Glucose and Risk Reduction of Complications from Diabetes II Diabetes in Control 212, 17, and Verdegem P, Freed S, Joffe D (2005) The clinical impact of fiber supplementation for the reduction of postprandial blood blucose and reduction of complications from type-2 diabetes Diabetes 54, A425.
Presented by Verdegem P, Freed S, Joffe D. The Clinical Impact of Fiber Supplementation on Cardio-Vascular Risk Parameters in type-2 Diabetes in 6th International Conference on Atherosclerosis, Thrombosis and Vascular Biology. 2005. Washinton, DC, USA. The American Heart Association sent out a press release on the study results.
abstract — poster — AHA press release
Presented by Verdegem P, Freed S, Joffe D. The Clinical Impact of Fiber Supplementation for the Reduction of Postprandial Blood Glucose and Risk Reduction of Complications from Type-2 Diabetes. in 65th Scientific Session American Diabetes Association. 2005. San Diego, CA, USA.
Philippines Trial by Dr. Yumul
Presented by Balajadia E, Valerio A, Yumul N. Beneficial effects of Bios Life 2 (Dietary Fiber Supplement) in patients with dyslipidemia. in 34th Annual Convention of the Philippine College of Physicians. 2004.
Utah Trial by Dr. Peter J.E. Verdegem
As published by Verdegem P (2007) Viscous soluble fiber combined with phytosterols and policosanol reduces LDL-c and increases HDL-c in hypercholesterolemia Current Topics in Neutraceutical Research.
Utah Trial #2 by Dr. Peter J.E. Verdegem
As presented by Verdegem P, Duenas V, Duenas J, Burke E. LDL- and HLD-cholesterol optimization using phytonutrient combination therapy: first line intervention and adjunct therapy to statins in 1st Asian Preventive Cardiology & Cardiac Rehabilitation Conference. 2006. Hong Kong.
Presented at the 7th International Congress on Coronary Artery Disease, 2007, Venice, Italy.
Pacific Rim Trial by Dr. Vincent Duenas
Published in Duenas V, Duenas J, Burke E, Verdegem P (2006) A new fiber drink can serve as an adjunct therapy to statin medication in mild hypercholesterolemia Arterioscler Thromb Vasc Biol 26, e53-e107.
Presented by Duenas V, Duenas J, Burke E, Verdegem P. A new fiber drink can serve as an adjunct therapy to statin medication in mild hypercholesterolemia. in 7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology. 2006. Denver.
abstract total user group — poster results total user group — poster results statin user group
Texas Trial by Dr. Isabel Martinez
Presented by Martinez I, Horne B, Verdegem P. Lipid and glucose optimization using phytonutrient combination therapy in diabetes. in 8th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology. 2007. Chicago.
Congestive Heart Failure trial by Dr. Jeejeebhoy
Published in Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction: Farida Jeejeebhoy, MD, Mary Keith, PhD, Michael Freeman, MD, Aiala Barr, PhD, Michele McCall, MSc, RD, Regina Kurian, BSc, David Mazer, MD, and Lee Errett, MD, Am Heart J 2002;143:1092-100. (the product MyoVive is marketed by our previous parent company and has the same ingredients as Cardio Essentials)
Coronary artery trial by Dr. Niedzwiecki
Published in Nutritional Supplement Program Halts Progression of Early Coronary Atherosclerosis
Documented by Ultrafast Computed Tomography Journal of Applied Nutrition 1996, 48: 67-78.
Carotid artery trial by Dr. Bill Curley
Presented at 7th Conference on Arteriosclerosis, Thrombosis and Vascular Biology, 2005, Washington, DC
abstract — poster
CM Plex Softgels study by Dr. Hesslink.
Published in Effect of a Cetylated Fatty Acid Topical Cream on Functional Mobility and Quality of Life of Patients with Osteoarthritis William J. Kraemer, Nicholas A. Ratamess, Jeffrey M. Anderson, Carl M. Maresh, David P. Tiberio, Michael E. Joyce, Barry N. Messinger, Duncan N. French, Matthew J. Sharman, Martyn R. Rubin, Aan L. Gomez, Jeff S. Volek, and Robert L. Hesslink Jr., J Rheumatol 2004;31:767–74
CM Plex Cream study by Dr. Kraemer.
Published in Cetylated Fatty Acids Improve Knee Function in Patients with Osteoarthritis
Robert Hesslink Jr., David Armstrong III, M.V. Nagendran, Srinan Sreevatsan, and Raj Barathur J. Rheumatol 2002;29:1708-12.
DP24 has been studied in relationship to its antioxidant potential. The study was presented at the 2004 Experimental Biology meeting by J.C. Young et al. with title “The Effect of Soluble Fiber on Glucose Tolerance and
Antioxidant Status in Insulin-Resistance Rats”
Currently, Omega Life 3 is being studied by Columbia University in New York City at the department of psychiatry to evaluate the effects on depression. More information will follow later.
VISUtein Study by Dr. David Newsome.